Samenvatting
Background Despite their carcinogenic potential, X-rays remain indispensable for electrophysiologic (EP) procedures. Objective The purpose of this study was to evaluate the dose reduction and image quality of a novel X-ray technology using advanced image processing and dose reduction technology in an EP laboratory. Methods In this single-center, randomized, unblinded, parallel controlled trial, consecutive patients undergoing catheter ablation for complex arrhythmias were eligible. The Philips Allura FD20 system allows switching between the reference (Allura Xper) and the novel X-ray imaging technology (Allura Clarity). Primary end-point was overall procedural patient dose, expressed in dose area product (DAP) and air kerma (AK). Operator dose, procedural success, and necessity to switch to higher dose settings were secondary end-points. Results A total of 136 patients were randomly assigned to the novel imaging group (n = 68) or the reference group (n = 68). Baseline characteristics were similar, except patients in the novel imaging group were younger (58 vs 65 years, P
Originele taal-2 | Nederlands |
---|---|
Pagina's (van-tot) | 1678-1682 |
Aantal pagina's | 5 |
Tijdschrift | Heart Rhythm |
Volume | 10 |
Nummer van het tijdschrift | 11 |
DOI's | |
Status | Gepubliceerd - 2013 |
Trefwoorden
- Ablation
- Atrial fibrillation
- Dose reduction
- Imaging
- Pulmonary vein isolation
- Radiation dose
Pers/Media
-
X-ray Dose Reduction in Electrophysiology
2/10/18
1 item van Media-aandacht
Pers / media: Vakinhoudelijk commentaar